Date Name Title Filing Type Shares Traded Price Total Held
Mar 09, 2020
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 96,736 -- 150,000
Mar 09, 2020
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 96,736 $30.63 614,535
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 96,736 -- 96,736
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 100,000 $8.77 688,235
Dec 03, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 100,000 -- --
Aug 03, 2018
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 101,187 -- 75,036
Aug 03, 2018
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 101,187 -- 487,141
Feb 24, 2020
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Open market or private sale of non-derivative or derivative security 118,123 $420.17 517,799
Dec 13, 2018
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Bona fide gift 118,993 -- --
Dec 13, 2018
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Bona fide gift 118,993 -- 602,594

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.